Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP334299.RA-YOU5uW6kVsd6bTs22w6aeY_n3g6LTTCaU4XsGVp6WI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP334299.RA-YOU5uW6kVsd6bTs22w6aeY_n3g6LTTCaU4XsGVp6WI130_assertion type Assertion NP334299.RA-YOU5uW6kVsd6bTs22w6aeY_n3g6LTTCaU4XsGVp6WI130_head.
- NP334299.RA-YOU5uW6kVsd6bTs22w6aeY_n3g6LTTCaU4XsGVp6WI130_assertion wasGeneratedBy ECO_0000203 NP334299.RA-YOU5uW6kVsd6bTs22w6aeY_n3g6LTTCaU4XsGVp6WI130_provenance.
- NP334299.RA-YOU5uW6kVsd6bTs22w6aeY_n3g6LTTCaU4XsGVp6WI130_assertion wasDerivedFrom befree-20150227 NP334299.RA-YOU5uW6kVsd6bTs22w6aeY_n3g6LTTCaU4XsGVp6WI130_provenance.
- NP334299.RA-YOU5uW6kVsd6bTs22w6aeY_n3g6LTTCaU4XsGVp6WI130_assertion SIO_000772 16381942 NP334299.RA-YOU5uW6kVsd6bTs22w6aeY_n3g6LTTCaU4XsGVp6WI130_provenance.
- NP334299.RA-YOU5uW6kVsd6bTs22w6aeY_n3g6LTTCaU4XsGVp6WI130_assertion evidence source_evidence_literature NP334299.RA-YOU5uW6kVsd6bTs22w6aeY_n3g6LTTCaU4XsGVp6WI130_provenance.
- NP334299.RA-YOU5uW6kVsd6bTs22w6aeY_n3g6LTTCaU4XsGVp6WI130_assertion description "[Tumor-associated antigens (TAAs) have been the most actively employed targets in the clinical diagnosis and treatment of human carcinoma, such as PSA in the diagnosis of prostate cancer and NY-ESO-1 in the immunotherapy of melanoma and other cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP334299.RA-YOU5uW6kVsd6bTs22w6aeY_n3g6LTTCaU4XsGVp6WI130_provenance.